Microgynon™ Fe, the world’s most frequently used oral contraceptive, is now available at a markedly reduced price from pharmacies in Uganda as the result of a new public-private partnership between Bayer HealthCare and the United States Agency for International Development (USAID). The price gives average-income couples in Uganda access to an affordable, high-quality family planning product. The successful partnership was launched in Ethiopia in December 2010 and rolled out in Uganda as well at a ceremony attended by Bayer HealthCare, USAID and the local Ministry of Health.
“This partnership is designed to offer women more affordable family planning alternatives,” said Dr. Jörg Reinhardt, Chairman of the Board of Management of Bayer HealthCare. Bayer and USAID plan to extend the initiative to numerous other sub-Saharan African countries by 2014.